Pharmaceutical packaging market seen reaching $198.7B by 2032

By AI, Created 7:01 AM UTC, June 03, 2026, /AGP/ – The global pharmaceutical packaging market is forecast to grow from $131.2 billion in 2025 to $198.7 billion by 2032, according to Persistence Market Research. Demand is being lifted by biopharmaceuticals, smart packaging, and stricter safety and sustainability requirements across major markets.

Why it matters: - Pharmaceutical packaging is a core part of drug safety, stability, and regulatory compliance. - The market’s growth reflects rising global healthcare demand, an aging population, and more complex drug delivery systems. - Biopharmaceuticals and personalized medicine are pushing demand for tamper-evident, high-barrier, and eco-friendly packaging. - The shift affects vials, syringes, bottles, blister packs, and other formats used across oral and injectable drugs.

What happened: - The global pharmaceutical packaging market is projected to reach $131.2 billion in 2025 and $198.7 billion by 2032. - The forecast implies a 6.1% compound annual growth rate from 2025 to 2032. - North America held a 38.5% market share in 2025. - Asia Pacific is the fastest-growing region. - Plastics held a 42.3% share in 2025. - Primary packaging generated more than 60.1% of market revenue.

The details: - Biopharmaceuticals, including monoclonal antibodies and mRNA vaccines, require sterile, high-barrier packaging such as Type I borosilicate glass vials and prefillable syringes. - India’s Production Linked Incentive scheme, introduced in 2021, is expected to boost demand for advanced packaging solutions by 2030. - The Indian government allocated Rs. 5,268.72 crore to the Department of Pharmaceuticals for FY 2025-26, up 28.8% from the prior year. - In emerging markets such as India, Ayushman Bharat and Health & Wellness Centre expansions are increasing pharmaceutical access. - Sustainable materials such as biopolymers and recyclable plastics face higher R&D and production costs. - The U.S. FDA’s CGMP rules and the EU’s Falsified Medicines Directive require validation, serialization, and quality assurance. - RFID tags, QR codes, and temperature indicators are gaining ground for traceability, transparency, and adherence. - Amcor plc is developing recyclable PET bottles and compostable pouches. - Government incentives for sustainable packaging in Europe and Asia are supporting innovation. - Oral drug delivery remains the largest segment by drug delivery format. - Injectable drug delivery is the fastest-growing segment. - Secondary packaging is the fastest-growing packaging segment.

Between the lines: - The market is being pulled in two directions at once: tighter regulation and lower waste are raising technical demands while cost pressure keeps commodity formats competitive. - Smart packaging is moving from a niche feature to a supply-chain and patient-engagement tool. - Regional policy matters. U.S. and Canadian regulatory standards support North America’s lead, while manufacturing incentives and healthcare investment are speeding Asia Pacific’s growth. - Europe’s sustainability rules are making recyclable and compostable formats more attractive, but also more expensive to develop.

What’s next: - Demand for advanced packaging should rise as biologics, vaccines, and injectable drugs take a larger share of pharmaceutical output. - Companies are likely to keep investing in smart packaging, sustainable materials, and manufacturing upgrades. - Competition is expected to remain intense among global suppliers such as Amcor plc, Gerresheimer AG, and Schott AG, alongside regional players like SGD Pharma. - Related market growth in pharmaceutical glass packaging and rigid packaging signals continued pressure for specialized materials and compliant formats.

The bottom line: - Pharmaceutical packaging is becoming more strategic, more regulated, and more technology-driven as drug makers balance safety, traceability, and sustainability.